VANGUARD GROUP INC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIOXXXX and the CUSIP is 71880W204. A total of 11 filers reported holding PHIO PHARMACEUTICALS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2019$5,000
-28.6%
26,4600.0%0.00%
Q3 2019$7,000
-30.0%
26,4600.0%0.00%
Q2 2019$10,000
-16.7%
26,4600.0%0.00%
Q1 2019$12,000
+33.3%
26,4600.0%0.00%
Q4 2018$9,00026,4600.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 155,135$51,0000.11%
SABBY MANAGEMENT, LLC 1,575,157$520,0000.11%
EDMOND DE ROTHSCHILD HOLDING S.A. 10,790$4,0000.00%
Advisor Group, Inc. 19$00.00%
BANK OF AMERICA CORP /DE/ 65$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SG Americas Securities, LLC 163,730$54,0000.00%
MORGAN STANLEY 5,718$2,0000.00%
BlackRock Inc. 1,115$00.00%
Citadel Advisors 19,886$7,0000.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders